Target intelligence / Profile preview

Intestinal microbiota adhesion sites and ecological niches

Molecular classification
Other
01

Overview

The intestinal microbiota adhesion sites and ecological niches represent the complex physical and chemical environments within the gastrointestinal tract that support microbial colonization and host-microbe interactions. Adhesion sites involve specific interactions between microbial surface components, such as adhesins (e.g., FimH), and host elements including the mucus layer, glycans, or epithelial cell surface receptors like CEACAMs (Donaldson et al., 2016, Nature Reviews Microbiology). Ecological niches are defined by localized physiological gradients, including oxygen tension, pH, nutrient availability, and bile acid concentrations, which determine the spatial organization and metabolic activity of the microbiota (Espey, 2013, Free Radical Biology and Medicine). While not a single molecular target, these niches are fundamental to maintaining gut homeostasis and are frequently disrupted in conditions such as inflammatory bowel disease and enteric infections. Therapeutic strategies targeting these environments aim to restore a healthy microbial balance or prevent pathogen colonization through the use of probiotics, prebiotics, or small molecules designed to block specific adhesion pathways (e.g., siboflanstat targeting FimH in Crohn's disease).

Other names
Gut microbiome nichesIntestinal colonization sitesMucosal adhesion sitesMicrobial habitatsGastrointestinal microenvironments
02

Mechanism of action

Modulation of microbial composition, competitive exclusion of pathogens, and pharmacological inhibition of bacterial adhesins to prevent host cell attachment.

03

Biological functions

Microbial colonizationHost-microbe interactionNutrient competitionImmune system modulationBarrier function maintenanceMetabolic homeostasis
04

Disease associations

Inflammatory bowel diseaseEnteric infectionDysbiosisIrritable bowel syndromeMetabolic syndromeColorectal cancer
05

Safety considerations

Disruption of commensal floraRisk of opportunistic infectionsPotential for bacterial translocationSystemic immune activation
06

Interacting drugs

Probiotics

5 more in the full profile.

07

Biomarkers

Microbial alpha-diversityMicrobial beta-diversityFecal calprotectinShort-chain fatty acid (SCFA) levelsSecretory IgA

Beyond the preview

Go deeper on Intestinal microbiota adhesion sites and ecological niches.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal microbiota adhesion sites and ecological niches.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call